Carboplatin
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Parenteral Medicines, Inc. | unknown | 8 | SUPPLYING |
| Hospira, Inc. | brand | 8 | SUPPLYING |
| Eugia US LLC | generic | 6 | SUPPLYING |
| BPI Labs LLC | unknown | 4 | SUPPLYING |
| Apotex Corp. | generic | 4 | SUPPLYING |
| Gland Pharma Limited | generic | 4 | SUPPLYING |
| Teyro Labs Private Limited | unknown | 4 | SUPPLYING |
| Natco Pharma Limited | unknown | 4 | SUPPLYING |
| Fresenius Kabi, USA LLC | generic | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Carboplatin Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Oncology.
Carboplatin Injection — reported in shortage by Eugia US LLC. Therapeutic category: Oncology.
Carboplatin Injection — reported in shortage by Teyro Labs. Therapeutic category: Oncology.
Carboplatin Injection — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Oncology.
Carboplatin Injection — reported in shortage by Gland Pharma Limited. Therapeutic category: Oncology.
Carboplatin Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Oncology.
Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico.
Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico.
Failed PH specification: The lots of Carboplatin Injection were manufactured from Carboplatin API lots which trended out of specification low pH. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico
The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are beig recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution. — Recalling firm: Hospira Inc. — Nationwide, including Puerto Rico and Guam. Product was also distributed internationally to Australia, Belgium, Cana…
